The Collaborative Influenza Vaccine Innovation Centers (CIVICs) will work together in a coordinated, multidisciplinary effort.

Monday, September 30, 2019 NIH Forms New Collaborative Influenza Vaccine Research Network As part of its ongoing commitment to developing better influenza vaccines, NIAID is establishing a network of research institutes known as the Collaborative Influenza Vaccine Innovation Centers (CIVICs) that will work together to coordinate their research on improving influenza vaccines. Each component of the network will have a role to play in designing, manufacturing and testing potential new influenza vaccines, as well as analyzing experimental results. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107